GWPH Latest Press Releases, GW Pharma Corporate News

Open account

Releases

218.96

0.00%

0.00

All
Financials
Insiders

4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
May 07,2021 16:21
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
May 07,2021 16:19
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
May 07,2021 16:15
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
May 07,2021 16:15
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
May 07,2021 16:15
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
May 07,2021 16:15
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
May 07,2021 16:15
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
May 07,2021 16:15
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
May 07,2021 16:15
S-8 POS GW PHARMACEUTICALS PLC (0001351288) (Filer)
May 05,2021 17:26
S-8 POS GW PHARMACEUTICALS PLC (0001351288) (Filer)
May 05,2021 17:25
8-K GW PHARMACEUTICALS PLC (0001351288) (Filer)
May 05,2021 17:23
25-NSE GW PHARMACEUTICALS PLC (0001351288) (Subject)
May 05,2021 08:54
10-Q GW PHARMACEUTICALS PLC (0001351288) (Filer)
Apr 30,2021 17:49
10-K/A GW PHARMACEUTICALS PLC (0001351288) (Filer)
Apr 30,2021 17:01
8-K GW PHARMACEUTICALS PLC (0001351288) (Filer)
Apr 23,2021 21:27
DEFA14A GW PHARMACEUTICALS PLC (0001351288) (Filer)
Apr 20,2021 09:14
8-K GW PHARMACEUTICALS PLC (0001351288) (Filer)
Apr 20,2021 09:10
DEFA14A GW PHARMACEUTICALS PLC (0001351288) (Filer)
Apr 14,2021 17:03
8-K GW PHARMACEUTICALS PLC (0001351288) (Filer)
Apr 14,2021 17:03
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Apr 08,2021 20:00
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 30,2021 20:00
DEFA14A GW PHARMACEUTICALS PLC (0001351288) (Filer)
Mar 25,2021 17:06
DEFA14A GW PHARMACEUTICALS PLC (0001351288) (Filer)
Mar 23,2021 17:33
DFAN14A GW PHARMACEUTICALS PLC (0001351288) (Subject)
Mar 23,2021 16:38
DEFA14A GW PHARMACEUTICALS PLC (0001351288) (Filer)
Mar 23,2021 16:06
8-K GW PHARMACEUTICALS PLC (0001351288) (Filer)
Mar 23,2021 16:02
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 22,2021 20:00
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 22,2021 20:00
DEFA14A GW PHARMACEUTICALS PLC (0001351288) (Filer)
Mar 15,2021 17:27
DEFM14A GW PHARMACEUTICALS PLC (0001351288) (Filer)
Mar 15,2021 16:28
SC 13G/A GW PHARMACEUTICALS PLC (0001351288) (Subject)
Mar 10,2021 11:42
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 04,2021 21:07
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 04,2021 21:05
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 04,2021 21:04
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 04,2021 21:01
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 02,2021 21:43
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 02,2021 21:43
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 02,2021 21:42
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 02,2021 21:42
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 02,2021 21:31
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 02,2021 21:27
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Mar 02,2021 21:25
DFAN14A GW PHARMACEUTICALS PLC (0001351288) (Subject)
Feb 26,2021 17:18
10-K GW PHARMACEUTICALS PLC (0001351288) (Filer)
Feb 26,2021 16:15
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Feb 25,2021 09:36
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Feb 24,2021 18:57
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Feb 24,2021 18:54
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Feb 24,2021 18:53
4 GW PHARMACEUTICALS PLC (0001351288) (Issuer)
Feb 24,2021 18:53

Webull provides the latest GW Pharma (GWPH) stock and general news. This information may help you make smarter investment decisions.

About GWPH

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.